Xi Zheng-Xiong, Gilbert Jeremy, Campos Arlene C, Kline Nicole, Ashby Charles R, Hagan Jim J, Heidbreder Christian A, Gardner Eliot L
Neuropsychopharmacology Section, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Psychopharmacology (Berl). 2004 Oct;176(1):57-65. doi: 10.1007/s00213-004-1858-y. Epub 2004 Apr 9.
The dopamine (DA) D3 receptor is preferentially expressed in the mesolimbic system. We have previously shown that selective D3 receptor blockade by the novel D3 antagonist SB-277011A inhibits cocaine's reinforcing action and cocaine-induced reinstatement of cocaine-seeking behavior.
In the present study, we investigated whether SB-277011A similarly inhibits stress-induced reinstatement of cocaine-seeking behavior.
Rats were allowed to self-administer cocaine (0.5 mg/kg per infusion, 3 h per session) for 10-14 days, followed by a once-daily extinction session for 7-14 days during which saline was substituted for cocaine. Extinction criteria were fewer than ten lever-presses per 3-h session for at least 3 consecutive days. After cocaine-seeking behavior was extinguished, each animal was tested twice for footshock-stress-induced reinstatement, once with vehicle (25% hydroxypropyl-beta-cyclodextrin) and once with one of three doses of SB-277011A in counterbalanced fashion.
During the last 3 days of cocaine self-administration (SA), active lever-presses were approximately 100 per session under fixed-ratio 2 reinforcement (approximately 25 mg/kg cocaine per session). After extinction, intermittent footshock (10 min, 0.5 mA, 0.5 s on with a mean inter-shock interval of 40 s) robustly reinstated the cocaine-seeking behavior (8.4+/-3.6 active lever-presses in last extinction session to 35.3+/-5.2 in animals after footshock stress). Intraperitoneal (i.p.) injections of SB-277011A (3, 6, and 12 mg/kg) dose-dependently blocked stress-induced reinstatement of cocaine-seeking. Reinstatement was also blocked by microinjections of SB-277011A (1.5 microg/0.5 microl per side) bilaterally into the nucleus accumbens, but not into the dorsal striatum.
The mesolimic DA D3 receptor plays an important role in mediating stress-induced reinstatement.
多巴胺(DA)D3受体在中脑边缘系统中优先表达。我们之前已经表明,新型D3拮抗剂SB - 277011A对D3受体的选择性阻断可抑制可卡因的强化作用以及可卡因诱导的觅药行为复现。
在本研究中,我们调查了SB - 277011A是否同样抑制应激诱导的觅药行为复现。
让大鼠自我给药可卡因(每次输注0.5mg/kg,每次实验3小时),持续10 - 14天,随后每天进行一次消退实验,持续7 - 14天,在此期间用生理盐水替代可卡因。消退标准为连续至少3天每3小时实验期间杠杆按压少于10次。在觅药行为消退后,对每只动物进行两次电击应激诱导复现实验,一次用赋形剂(25%羟丙基-β-环糊精),一次用三种剂量之一的SB - 277011A,采用平衡设计。
在可卡因自我给药(SA)的最后3天,在固定比率2强化条件下(每次实验约25mg/kg可卡因),每次实验的主动杠杆按压约为100次。消退后,间歇性电击(10分钟,0.5mA,每次电击持续0.5秒,平均电击间隔40秒)强烈复现了觅药行为(在最后一次消退实验中为8.4±3.6次主动杠杆按压,在电击应激后的动物中为35.3±5.2次)。腹腔注射SB - 277011A(3、6和12mg/kg)剂量依赖性地阻断了应激诱导的觅药行为复现。双侧伏隔核微量注射SB - 277011A(每侧1.5μg/0.5μl)也阻断了复现,但双侧背侧纹状体微量注射则未阻断。
中脑边缘多巴胺D3受体在介导应激诱导的复现中起重要作用。